Skip navigation
Skip navigation

Advax, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety

Petrosky, Nikolai; Cooper, Peter


There is an ongoing need for new adjuvants to facilitate development of vaccines against HIV, tuberculosis, malaria and cancer, amongst many others. Unfortunately, the most potent adjuvants are often associated with toxicity and safety issues. Inulin, a plant-derived polysaccharide, has no immunological activity in its native soluble form but when crystallized into a stable microcrystalline particulate from (delta inulin) acquires potent adjuvant activity. Delta inulin has been shown to enhance...[Show more]

CollectionsANU Research Publications
Date published: 2015
Type: Journal article
Source: Vaccine
DOI: 10.1016/j.vaccine.2015.09.030


File Description SizeFormat Image
01_Petrosky_Advax%2C_a_novel_2015.pdf1.06 MBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  17 November 2022/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator